Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
AFC-HD AMS Life Science Co.,Ltd., Last Fiscal Year Ordinary Profit Revised Upward by 8%
2927 AFC-HD AMS Life Science Co.,Ltd. 【J-GAAP】
Guidance Update ReportAFC-HD AMS Life Science Co.,Ltd. <2927> [TSE-S] announced a performance revision after the market closed on September 17th (15:00). The consolidated ordinary profit for the fiscal year ending August 2024 has been revised upward by 7.6%, from the previous forecast of 1.78 billion yen to 1.92 billion yen (compared to 1.65 billion yen in the previous period), increasing the growth rate from 8.1% to 16.3%.
Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the March to August period (second half) consolidated ordinary profit has been revised upward by 18.5%, from the previous forecast of 728 million yen to 863 million yen (compared to 946 million yen in the same period of the previous year), and the declining rate is expected to decrease from 23.0% to 8.8%.
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 Prev | 13,913 | 778 | 728 | 482 | 34.3 | 15 | Apr 15, 2024 | J-GAAP |
Mar - Aug, 2024 New | 15,692 | 871 | 863 | 513 | 36.6 | 15 | Sep 17, 2024 | J-GAAP |
Revision Rate | +12.8% | +12.0% | +18.5% | +6.4% | +6.6% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Aug, 2024 Prev | 28,455 | 1,801 | 1,788 | 1,123 | 79.9 | 30 | Oct 13, 2023 | J-GAAP |
Aug, 2024 New | 30,234 | 1,894 | 1,923 | 1,154 | 82.2 | 30 | Sep 17, 2024 | J-GAAP |
Revision Rate | +6.3% | +5.2% | +7.6% | +2.8% | +2.9% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2023 | 13,135 | 958 | 946 | 688 | 49.0 | 15 | Oct 13, 2023 | J-GAAP |
Mar - Aug, 2024 Guidance | 15,692 | 871 | 863 | 513 | 36.6 | 15 | Sep 17, 2024 | J-GAAP |
YoY | +19.5% | -9.1% | -8.8% | -25.4% | -25.4% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Aug, 2022 | 23,024 | 1,015 | 1,343 | 735 | 52.3 | 30 | Oct 14, 2022 | J-GAAP |
Aug, 2023 | 25,579 | 1,636 | 1,654 | 1,102 | 78.5 | 27.50 | Oct 13, 2023 | J-GAAP |
Aug, 2024 Guidance | 30,234 | 1,894 | 1,923 | 1,154 | 82.2 | 30 | Sep 17, 2024 | J-GAAP |
YoY | +18.2% | +15.8% | +16.3% | +4.7% | +4.7% |
Related Articles
T&S Group Inc., Current Fiscal Year Dividend Revised Upward by 1 yen
SanBio Company Limited, 2Q (May-July) Net Income Loss Widens
Japan Living Warranty Inc., Previously Undecided Dividend for Current Fiscal Year to Rise by 5 yen
FCE Inc., Previously Undecided Dividend for Current Fiscal Year Set at 12 yen, Resuming Dividends for the First Time in Four Terms
SANEI LTD., Current Fiscal Year Dividend Revised Upward by 2.5 yen
TOKYO BASE Co., Ltd., First Half Ordinary Profit Increases by 32%
Tokaido REIT,Inc., 3% Increase in Ordinary Profit, Update Record High for Sixth Consecutive Term
System D Inc., Third Quarter Cumulative (November-July) Ordinary Profit Decreases by 11%, 3Q (May-July) Ordinary Profit Decreases by 80%
Atrae, Inc., The Current Fiscal Year Ordinary Profit Revised Upward by 8%, Exceeded record profit forecast, Dividend Revised Upward by 1 yen
COSEL CO.,LTD., 1Q (June-August) Ordinary Profit Decreases by 80%